From: Managing an effective treatment for neuroleptic malignant syndrome
Effectiveness within 24 hoursa | Complete remission in days | Mortality | ||
---|---|---|---|---|
Yes | No | |||
Dantrolene monotherapy | 23 (76.7%) | 7 (23.3%) | 9.4 (SD 12.7) | 6/37 (16.2%) |
Dantrolene with additive medication | 30 (44.1%) | 38 (55.9%) | 19.0 (SD 31.6) | 6/82 (7.3%) |
Other medication | 44 (67.7%) | 21 (32.3%) | 9.5 (SD 9.8) | 9/101 (8.9%) |
Only supportive therapy | 9 (37.5%) | 15 (62.5%) | 9.2 (SD 18.4) | 1/51 (2.0%) |